ALPHARETTA, Ga., Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day.The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer.To join ...

Avanos Medical (AVNS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Si ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use tried-and-true metrics and fundamental analysis to find companies that they beli ...

Avanos Medical, Inc. (AVNS) is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism led by a solid fiscal second-quarter 2024 performance and continued focus on its research and development (R&D) are expected to contribute further. However, macroeconomic concerns and foreign exchange volatility persist.In the year-to-date period, this Zacks Rank #2 (Buy) stock has gained 3.7% compared with the 8.4% rise of the industry and 20% growth of the S&P 500 Composite.T ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued ...

Avanos Medical’s (AVNS) state-of-the-art recovery system brand, GAME READY, recently announced a new partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa. As part of this partnership, GAME READY has been named the Official Recovery Partner of Nick Bosa. This collaboration is a paid partnership between Avanos Medical and Nick Bosa.Avanos Medical’s GAME READY provides innovative, multi-modality recovery systems for injury treatment and physical therapy. The brand’s products are used by t ...

ALPHARETTA, Ga., Sept. 9, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 22nd Annual Best Ideas Conference 2024 on Mon., Sept. 16 at approximately 9:30 a.m. Eastern Time.A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.About Avan ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving ...

Avanos Medical, Inc. (AVNS) reported second-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 34 cents, up 41.7% year over year. The bottom line surpassed the Zacks Consensus Estimate by 17.2%.GAAP EPS from continuing operations in the quarter under review was 9 cents against the year-ago period’s loss of 9 cents per share.RevenuesRevenues grossed $171.7 million in the reported quarter, up 1.4% year over year. The metric beat the Zacks Consensus Estimate by 0.4%.Organic sales were ...

Avanos Medical, Inc. (NYSE:AVNS) Q2 2024 Earnings Conference Call July 31, 2024 9:00 AM ET Company Participants Scott Galovan - SVP, Strategy & Corporate Development Joe Woody - Chief Executive Officer Michael Greiner - SVP, Chief Financial Officer & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical Q2 2024 Earnings Call. At this time, all lines ar ...